# Sinopia Biosciences Gets NIH AI Drug Discovery Grant

> Sinopia Biosciences secures $2.5m NIH grant to build AI metabolomics model for drug discovery.
- Title: Sinopia Biosciences Gets NIH AI Drug Discovery Grant
- Summary: Sinopia Biosciences secures $2.5m NIH grant to build AI metabolomics model for drug discovery. Sinopia Biosciences received a $2.5 million NIH grant to…
- Keywords: sinopia biosciences, nih, ai metabolomics, drug discovery, leads platform, pkl-0110, parkinsons disease, startups, business, Sinopia, Biosciences, Gets
- Source: Pulse 2.0 — https://pulse2.com/sinopia-biosciences-secures-2-5-million-nih-grant-for-ai-metabolomics-drug-discovery-model
- Author: Amit Chowdhry
- Published: 2026-10-21T19:32:02+00:00
- Read time: 1 min
- Topics: sinopia biosciences, nih, ai metabolomics, drug discovery, leads platform, pkl-0110, parkinsons disease, startups, business
## NIH Grant Award
Sinopia Biosciences received a $2.5 million Small Business Innovation Research Phase II grant from the National Institute of General Medical Sciences, part of the National Institutes of Health.
## AI Metabolomics Model
The grant supports development and validation of an AI-powered model to integrate metabolomics data across experimental platforms, analytical methods, laboratories, and studies.
## LEADS Platform Integration
Sinopia plans to incorporate the technology into its proprietary LEADS platform, which combines multi-omics data, high-throughput screening, and AI and machine learning.
## Drug Discovery Focus
The model aims to identify consistent mechanisms, targets, and compounds by learning shared biological patterns across diverse metabolomics datasets.
## Key takeaway

Sinopia Biosciences received a $2.5 million NIH grant to develop an AI-powered metabolomics foundation model for drug discovery.